Combined cellular and immunosuppresive therapies

Details Combined cellular and immunosuppresive therapies Combined cellular and immunosuppresive therapies

A - Human Necessities

61

K

A61K 35/12 (2006.01) A61K 35/36 (2006.01) A61K 38/13 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2121487

2121487 9307887 PCTABS00021 Novel regimens are provided for administering foreign genetically modifided allogeneic cells to a host by combining the administration of the cells with a reduced regimen of an immunosuppressive agent. Particularly, cells having a reduced level of Class I MHC antigens may be employed in a variety of cellular therapy situations, where foreign cells are engrafted to treat diseased states.

Affiliated with

Also associated with

Rating

Combined cellular and immunosuppresive therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined cellular and immunosuppresive therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined cellular and immunosuppresive therapies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1433179